Latest Lead News

Ryman Healthcare reported a 13% revenue increase to NZD 413.8 million for H1 2025, yet swung to a significant net loss of NZD 45.2 million and suspended dividends, raising questions about its financial trajectory.

National Storage REIT has received a conditional, non-binding proposal from a Brookfield and GIC consortium to acquire all stapled securities at $2.86 each, triggering an exclusivity period for negotiations.

Airtasker Limited showcased strong FY25 financials and unveiled aggressive growth plans in the UK and US, supported by strategic media partnerships and core platform investments.

ASX Compliance has flagged Rent.com.au Limited for a late filing of a director’s interest change, raising questions about the company’s disclosure controls and compliance with listing rules.

MotorCycle Holdings Limited delivered a standout FY2025 with double-digit revenue and profit growth, underpinned by strong market share gains and operational efficiencies.

MotorCycle Holdings Limited reported a robust 2025 financial year with record revenue and profit growth, strengthened by key acquisitions that expanded its market share to 22%. The company’s focus on operational efficiency and digital transformation sets the stage for continued momentum in 2026.

Anatara Lifesciences has completed the final tranche of its placement, issuing over 66 million shares and granting options to its lead manager, marking a key step in its capital raising strategy.

Maggie Beer Holdings reveals strategic progress in its 2025 AGM, focusing on operational simplification, financial stability, and targeted growth for its iconic brands.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

PainChek Ltd has secured FDA De Novo clearance for its Adult App, marking a pivotal entry into the US long-term care market and setting the stage for global expansion including its Infant App.

Recce Pharmaceuticals has reported compelling preclinical results for its inhaled anti-infective RECCE 327, demonstrating potent activity against multidrug-resistant pneumonia bacteria in mice models.

Eclipse Metals has engaged BGR Group, a leading U.S. government relations firm, to strengthen its strategic positioning and funding prospects for its Greenland rare earth projects, advancing its role in Western critical minerals supply chains.